This information was published on 2024-08-12T08:57:39 for Full Assignment - Subsequent Applicant Recorded Published.
| Field | Value |
| (210) | 2465491 |
| (220) |
11 Jul 2024
|
| (511) (510) |
Class 5
nicotine gum for use as an aid to stop smoking; nicotine-containing lozenges for medical use; nicotine patches for use as aids to stop smoking; nicotine-free snuff for medical purposes; nicotine inhalers for medical purposes; nicotine patches for medical purposes; nicotine-free snuff for medical use; nicotine-free snus for medical use; nicotine-free snus for medical purposes; aconitine Class 34 vaping devices being electronic cigarettes; liquid nicotine solutions for e-cigarettes; liquid nicotine solutions for use in electronic cigarettes; liquid nicotine solutions for use in e-cigarettes; liquid nicotine solutions for electronic cigarettes; electronic devices for nicotine inhalation; electronic nicotine inhalation devices; electronic devices for the inhalation of nicotine containing aerosol; electronic devices for the inhalation of nicotine-containing aerosols; electronic devices for nicotine inhalation containing an aerosol |
| (540) | Quell pharmaceuticals |
| (550) | Word |
| (730) |
Quell Pharmaceuticals Pty Ltd
ACN/ABN 679258550 |
| (750) |
Maddocks
|
Find out more about publications on the About page.